George W. Lloyd

Insider Reports History

Location
C/O Royalty Pharma Plc, 110 East 59 Th Street, New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George W. Lloyd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 292K $96.7M $331.50 Aug 6, 2025 By GWL 2014 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 273K $90.4M $331.50 Aug 6, 2025 By GWL 2020 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 130K $43.1M $331.50 Aug 6, 2025 By GWL 2021 G LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 496K $19.7M $39.73 Dec 3, 2025 By GWL 2013 NG, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 58.2K $19.3M $331.50 Aug 6, 2025 By GWL 2013 NG, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 274K $10.9M $39.73 Dec 3, 2025 By IRA
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 110K $4.38M $39.77 Dec 3, 2025 By GWL 2014 G, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 6.08K $242K $39.73 Dec 3, 2025 By GWL 2023 G HoldCo LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 4.01K $159K $39.73 Dec 3, 2025 By Spouse
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 0 $0 $331.50 Aug 8, 2025 Direct
Royalty Pharma plc EVP, Investments & CLO Class E Ordinary Shares 1.94M May 16, 2025 Indirect

Insider Reports Filed by George W. Lloyd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc Dec 3, 2025 1 -$4.38M 4 Dec 5, 2025 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 19, 2025 8 -$5.19M 4 Nov 21, 2025 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 5, 2025 1 $0 4 Nov 7, 2025 EVP, Investments & CLO
RPRX Royalty Pharma plc Aug 6, 2025 2 $0 4 Aug 8, 2025 EVP, Investments & CLO
RPRX Royalty Pharma plc May 16, 2025 1 $0 4 May 20, 2025 EVP, Investments & CLO
RPRX Royalty Pharma plc May 8, 2025 1 $0 4 May 9, 2025 EVP, Investments & CLO
RPRX Royalty Pharma plc Aug 12, 2024 1 $0 4 Aug 12, 2024 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 13, 2023 4 $0 4 Nov 14, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Aug 8, 2023 1 $0 4 Aug 8, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Jun 2, 2023 4 -$6.48M 4 Jun 6, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Mar 28, 2023 2 -$4.18M 4 Mar 30, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Feb 23, 2023 1 -$932K 4 Feb 27, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 21, 2022 4 -$1.73M 4 Nov 22, 2022 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 10, 2022 3 -$2.19M 4 Nov 14, 2022 EVP, Investments & CLO
RPRX Royalty Pharma plc Aug 9, 2022 2 -$916K 4 Aug 11, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 28, 2022 1 -$178K 4 Aug 1, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 25, 2022 6 -$3.25M 4 Jul 27, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc May 26, 2022 2 -$4.03M 4 May 31, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc May 23, 2022 1 -$4.03M 4 May 25, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc Nov 16, 2021 5 -$10.6M 4 Nov 18, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 26, 2021 2 -$532K 4 Jul 27, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 12, 2021 3 -$972K 4 Jul 14, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 6, 2021 6 -$3.73M 4 Jul 8, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jun 10, 2021 3 -$3.25M 4 Jun 14, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jun 4, 2021 12 -$11.6M 4 Jun 8, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jun 2, 2021 2 -$2.63M 4 Jun 4, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc May 7, 2021 6 $0 4 May 11, 2021 EVP, Investments & GC